wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48522177-AFF3626E-165C-426D-BC3F-88664A913E34
Q48522177-AFF3626E-165C-426D-BC3F-88664A913E34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48522177-AFF3626E-165C-426D-BC3F-88664A913E34
Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.
P2860
Q48522177-AFF3626E-165C-426D-BC3F-88664A913E34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48522177-AFF3626E-165C-426D-BC3F-88664A913E34
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b858d410d7bc0f58c362a8075f617d5e6b86b2a0
P2860
The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma.